RhumbLine Advisers’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.1M | Buy |
272,715
+100
| +0% | +$12.1K | 0.02% | 582 |
|
|
2026
Q1 | $44.6M | Buy |
272,615
+4,289
| +2% | +$659K | 0.04% | 389 |
|
|
2025
Q4 | $46.7M | Buy |
268,326
+55,423
| +26% | +$10.1M | 0.04% | 374 |
|
|
2025
Q3 | $30.7M | Buy |
212,903
+4,558
| +2% | +$558K | 0.02% | 543 |
|
|
2025
Q2 | $21M | Sell |
208,345
-95,212
| -31% | -$7.28M | 0.02% | 682 |
|
|
2025
Q1 | $23.2M | Buy |
303,557
+15,220
| +5% | +$1.16M | 0.02% | 612 |
|
|
2024
Q4 | $19.9M | Buy |
288,337
+25,292
| +10% | +$1.82M | 0.02% | 698 |
|
|
2024
Q3 | $19.2M | Buy |
263,045
+26,518
| +11% | +$1.96M | 0.02% | 740 |
|
|
2024
Q2 | $15.8M | Buy |
236,527
+28,865
| +14% | +$1.12M | 0.01% | 800 |
|
|
2024
Q1 | $5.63M | Buy |
207,662
+3,966
| +2% | +$111K | 0.01% | 1351 |
|
|
2023
Q4 | $6.31M | Buy |
203,696
+6,053
| +3% | +$157K | 0.01% | 1278 |
|
|
2023
Q3 | $4.99M | Buy |
197,643
+4,081
| +2% | +$93.3K | 0.01% | 1346 |
|
|
2023
Q2 | $4.08M | Buy |
193,562
+5,890
| +3% | +$112K | ﹤0.01% | 1498 |
|
|
2023
Q1 | $3.2M | Buy |
187,672
+5,307
| +3% | +$103K | ﹤0.01% | 1570 |
|
|
2022
Q4 | $3.64M | Buy |
182,365
+22,254
| +14% | +$430K | ﹤0.01% | 1463 |
|
|
2022
Q3 | $3.45M | Buy |
160,111
+13,872
| +9% | +$333K | 0.01% | 1448 |
|
|
2022
Q2 | $2.88M | Buy |
146,239
+18,462
| +14% | +$387K | ﹤0.01% | 1561 |
|
|
2022
Q1 | $3M | Buy |
127,777
+5,723
| +5% | +$133K | ﹤0.01% | 1600 |
|
|
2021
Q4 | $3.33M | Sell |
122,054
-408
| -0.3% | -$11.7K | ﹤0.01% | 1601 |
|
|
2021
Q3 | $3.37M | Buy |
122,462
+6,601
| +6% | +$173K | ﹤0.01% | 1590 |
|
|
2021
Q2 | $3.3M | Sell |
115,861
-4,469
| -4% | -$133K | ﹤0.01% | 1668 |
|
|
2021
Q1 | $4.1M | Sell |
120,330
-14,436
| -11% | -$552K | 0.01% | 1522 |
|
|
2020
Q4 | $4.49M | Buy |
134,766
+4,249
| +3% | +$155K | 0.01% | 1414 |
|
|
2020
Q3 | $4.2M | Sell |
130,517
-29,645
| -19% | -$852K | 0.01% | 1280 |
|
|
2020
Q2 | $4.41M | Buy |
160,162
+32,190
| +25% | +$763K | 0.01% | 1284 |
|
|
2020
Q1 | $2.05M | Buy |
127,972
+2,763
| +2% | +$65.5K | ﹤0.01% | 1531 |
|
|
2019
Q4 | $2.99M | Buy |
125,209
+8,380
| +7% | +$170K | 0.01% | 1568 |
|
|
2019
Q3 | $2.06M | Buy |
116,829
+7,409
| +7% | +$143K | ﹤0.01% | 1729 |
|
|
2019
Q2 | $2.8M | Buy |
109,420
+6,808
| +7% | +$190K | 0.01% | 1521 |
|
|
2019
Q1 | $2.98M | Sell |
102,612
-120
| -0.1% | -$3.11K | 0.01% | 1478 |
|
|
2018
Q4 | $1.35M | Buy |
102,732
+32,813
| +47% | +$524K | ﹤0.01% | 1871 |
|
|
2018
Q3 | $1.41M | Sell |
69,919
-4,840
| -6% | -$109K | ﹤0.01% | 1840 |
|
|
2018
Q2 | $1.77M | Buy |
74,759
+1,540
| +2% | +$39.6K | ﹤0.01% | 1735 |
|
|
2018
Q1 | $1.65M | Sell |
73,219
-1,355
| -2% | -$35.7K | ﹤0.01% | 1710 |
|
|
2017
Q4 | $2.33M | Sell |
74,574
-10,798
| -13% | -$319K | ﹤0.01% | 1538 |
|
|
2017
Q3 | $2.66M | Buy |
85,372
+12,392
| +17% | +$236K | 0.01% | 1419 |
|
|
2017
Q2 | $1.25M | Sell |
72,980
-502
| -0.7% | -$8.57K | ﹤0.01% | 1836 |
|
|
2017
Q1 | $1.29M | Buy |
73,482
+2,533
| +4% | +$39.1K | ﹤0.01% | 1801 |
|
|
2016
Q4 | $939K | Buy |
70,949
+3,608
| +5% | +$49.2K | ﹤0.01% | 1885 |
|
|
2016
Q3 | $978K | Sell |
67,341
-220
| -0.3% | -$2.75K | ﹤0.01% | 1822 |
|
|
2016
Q2 | $666K | Buy |
67,561
+2,745
| +4% | +$32K | ﹤0.01% | 2019 |
|
|
2016
Q1 | $821K | Buy |
64,816
+5
| +0% | +$66 | ﹤0.01% | 1915 |
|
|
2015
Q4 | $1.18M | Buy |
64,811
+4,735
| +8% | +$83.4K | ﹤0.01% | 1704 |
|
|
2015
Q3 | $1.12M | Buy |
60,076
+1,621
| +3% | +$40.5K | ﹤0.01% | 1698 |
|
|
2015
Q2 | $1.43M | Buy |
58,455
+9,250
| +19% | +$210K | ﹤0.01% | 1639 |
|
|
2015
Q1 | $1.02M | Buy |
49,205
+6,975
| +17% | +$123K | ﹤0.01% | 1844 |
|
|
2014
Q4 | $653K | Buy |
42,230
+3,060
| +8% | +$43.4K | ﹤0.01% | 2096 |
|
|
2014
Q3 | $511K | Buy |
39,170
+3,195
| +9% | +$48.2K | ﹤0.01% | 2207 |
|
|
2014
Q2 | $719K | Buy |
35,975
+4,193
| +13% | +$62.1K | ﹤0.01% | 2046 |
|
|
2014
Q1 | $605K | Sell |
31,782
-1,380
| -4% | -$26.2K | ﹤0.01% | 2096 |
|
|
2013
Q4 | $564K | Buy |
33,162
+2,600
| +9% | +$39.8K | ﹤0.01% | 2182 |
|
|
2013
Q3 | $477K | Buy |
30,562
+5,142
| +20% | +$65.3K | ﹤0.01% | 2240 |
|
|
2013
Q2 | $304K | Buy |
+25,420
| New | +$260K | ﹤0.01% | 2632 |
|
Other funds holding INSM
VPM
VCM
RhumbLine Advisers's INSM Position: Q2 2026 in Review
RhumbLine Advisers increased its Insmed (INSM) stake by 0.04% in Q2 2026, buying an estimated $12.1K and bringing the position to 272,715 shares worth $29.1M. The position accounts for 0.02% of the portfolio, ranked #582.
RhumbLine Advisers first reported a position in INSM in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.7M in Q4 2025. 462 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- RhumbLine Advisers held 272,715 shares of Insmed worth $29.1M as of Q2 2026.
- RhumbLine Advisers bought 100 Insmed shares in Q2 2026, an estimated $12.1K.
- Insmed made up 0.02% of RhumbLine Advisers's portfolio in Q2 2026, its #582 holding.
- RhumbLine Advisers first reported a position in Insmed in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Insmed position peaked at $46.7M in Q4 2025.
- 462 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.